Impact of Two Different Antiglaucomatous Medications on Corneal Endothelium and Transparency: A Comparative Perspective

This is a preliminary investigation to conduct a comparative analysis of corneal clarity in patients who are under antiglaucomatous medication and in a healthy population. It can be postulated that a reduction in CD values in the latanoprost-treated group may contribute to an improvement in corneal transparency due to the remodeling effect of the drug on the cornea. It can also be inferred that the lower CCT observed in the latanoprost-treated group may be attributed to the lower CD measurements in these eyes.